0000950170-24-070884.txt : 20240607
0000950170-24-070884.hdr.sgml : 20240607
20240607171742
ACCESSION NUMBER: 0000950170-24-070884
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rothenberg Mace
CENTRAL INDEX KEY: 0001873988
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39485
FILM NUMBER: 241030694
MAIL ADDRESS:
STREET 1: 171 OYSTER POINT BLVD., SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tango Therapeutics, Inc.
CENTRAL INDEX KEY: 0001819133
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 BROOKLINE AVENUE
STREET 2: SUITE 901
CITY: BOSTON
STATE: MA
ZIP: 02215
BUSINESS PHONE: (857) 320-4900
MAIL ADDRESS:
STREET 1: 201 BROOKLINE AVENUE
STREET 2: SUITE 901
CITY: BOSTON
STATE: MA
ZIP: 02215
FORMER COMPANY:
FORMER CONFORMED NAME: BCTG Acquisition Corp.
DATE OF NAME CHANGE: 20200723
4
1
ownership.xml
4
X0508
4
2024-06-05
0001819133
Tango Therapeutics, Inc.
TNGX
0001873988
Rothenberg Mace
C/O TANGO THERAPEUTICS, INC
201 BROOKLINE AVE., SUITE 901
BOSTON
MA
02215
true
false
false
false
false
Common Stock
2024-06-05
4
A
false
6250
0.00
A
11250
D
Stock Option (Right to Buy)
7.41
2024-06-05
4
A
false
37500
0.00
A
2034-06-05
Common Stock
37500
37500
D
These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2025 and (iii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 5, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
/s/ Douglas Barry, as attorney-in-fact
2024-06-07